# Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer

> **NCT01259284** · PHASE2,PHASE3 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 2 (actual)

## Conditions studied

- Advanced Cancers

## Interventions

- **DRUG:** Atorvastatin
- **DIETARY_SUPPLEMENT:** Fish Oil Supplement
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01259284
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-01
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Terminated due to low accrual.
- **Last updated:** 2012-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01259284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01259284, "Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01259284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*